Kerry Morgan, MD
Cardiovascular Disease · Corinth, MSNPI 1194749150
Payments from drug & device makers
Across 399 payments — averaging $22.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$785
- Medtronic$750
- Biotronik Inc.$609
- Abiomed$606
- Merck$432
- plus $5K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $1,064 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 55 | $785 |
| Medtronic(2 entities) | 27 | $750 |
| Biotronik Inc. | 13 | $609 |
| Abiomed | 22 | $606 |
| Merck | 26 | $432 |
| Amgen | 28 | $378 |
| Cvrx, Inc. | 3 | $357 |
| Johnson & Johnson | 22 | $356 |
| Boston Scientific | 19 | $322 |
| Boehringer Ingelheim | 19 | $305 |
| Amarin Pharma, Inc. | 13 | $250 |
| Novartis | 16 | $224 |
| Esperion Therapeutics, Inc. | 7 | $222 |
| Abbott | 6 | $220 |
| Pfizer | 14 | $218 |
| Daiichi Sankyo Inc. | 6 | $208 |
| Veryan Medical Incorporated | 4 | $189 |
| Penumbra, Inc. | 10 | $184 |
| Novo Nordisk | 3 | $169 |
| E.r. Squibb & Sons, L.L.C. | 4 | $167 |
| Opsens Inc. | 1 | $118 |
| Lexicon Pharmaceuticals, Inc. | 6 | $105 |
| Bard Peripheral Vascular, Inc. | 1 | $103 |
| Kowa Pharmaceuticals America, Inc. | 7 | $100 |
| Avinger Inc. | 2 | $98 |
| Daxor Corporation | 4 | $79 |
| Philips North America LLC | 3 | $76 |
| Bardy Diagnostics, Inc. | 4 | $60 |
| Cardiva Medical, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Edwards Lifesciences | 1 | $30 |
| Baxter Healthcare | 2 | $28 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| Terumo Medical Corporation | 1 | $15 |
| Vifor Pharma, Inc. | 1 | $14 |
How this compares
$8,960 in reported general payments places this provider in the 65th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Corinth
- Mandar JagtapCorinth$20K
- Nanni PidikitiCorinth$13K
- Barry BertoletTupelo$6.4M
- Dharmesh PatelSouthaven$1.9M
- James HaysJackson$782K
- John EstessTupelo$416K
- Donny StokesJackson$277K
- Mahmoud ZayedPascagoula$103K
- Benjamin BlossomTupelo$91K
- James HaysJackson$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.